Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Impact of slim-CRAB criteria on diagnostic practices among patients with MGUS in the veteran health administration

Mengmeng Ji, Mahta Salehi, Mei Wang, John Huber, Rong Wang, Shi-Yi Wang, Martin Schoen, Su-Hsin Chang

Blood (2025) 146 (Supplement 1): 3972.

https://doi.org/10.1182/blood-2025-3972

Published: 2025

Journal Articles

Association between monoclonal gammopathy of undetermined significance and cardiovascular disease risk among individuals with type 2 diabetes: A Taiwan nationwide Study

Tzeyu Michaud, Mei Wang, Pin-Xiang Chen, Ming-Che Hu, Chia-Cheng Wei, Su-Hsin Chang

Blood (2025) 146 (Supplement 1): 3966.

https://doi.org/10.1182/blood-2025-3966

Published: 2025

Journal Articles

Impact of slim-CRAB criteria on treatment initiation in newly diagnosed multiple myeloma in the veteran health administration

Mengmeng Ji, Mahta Salehi, Mei Wang, John Huber, Rong Wang, Shi-Yi Wang, Martin Schoen, Su-Hsin Chang

Blood (2025) 146 (Supplement 1): 6378.

https://doi.org/10.1182/blood-2025-6378

Published: 2025

Journal Articles

Identification of dynamic markers for multiple myeloma in patients with MGUS and T2DM

Mei Wang, Yuan-Hung Kuan, Jr-Shin Li, Su-Hsin Chang

Blood (2025) 146 (Supplement 1): 5784.

https://doi.org/10.1182/blood-2025-5784

Published: 2025

Journal Articles

The association between sglt-2 inhibitor use and progression from monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans

Byron Sigel, Lawrence Liu, Mei Wang, Qingyuan Tan, Martin Schoen, Kristen Sanfilippo, Murali Janakiram, Theodore Thomas, Su-Hsin Chang

Blood (2025) 146 (Supplement 1): 4027.

https://doi.org/10.1182/blood-2025-4027

Published: 2025

Journal Articles

Descriptive analysis of IgM monoclonal gammopathy of undetermined significance progression events in US veterans

Lawrence Liu, Byron Sigel, Mei Wang, Qingyuan Tan, Kristen Sanfilippo, Theodore Thomas, Murali Janakiram, Martin Schoen, Su-Hsin Chang

Blood (2025) 146 (Supplement 1): 5750.

https://doi.org/10.1182/blood-2025-5750

Published: 2025

Journal Articles

Type 2 Diabetes Mellitus Increases the Risk for Developing Monoclonal Gammopathy of Undetermined Significance in Asian Populations

Su-Hsin Chang, Mei Wang, Pin-Xiang Chen, Sylvia H Hsu, Ming-Che Hu, Chia-Cheng Wei

Blood (2024) 144 (Supplement 1): 6898.

https://doi.org/10.1182/blood-2024-211127

Published: 2024

Journal Articles

The Association between Rheumatological Diseases and Monoclonal Gammopathy of Undetermined Significance

Mahta Salehi, Nathan Logan, Mei Wang, Qingyuan Tan, Martin W Schoen, Su-Hsin Chang

Blood (2024) 144 (Supplement 1): 6897.

https://doi.org/10.1182/blood-2024-210655

Published: 2024

Journal Articles

The Association between Cumulative Excess Body Mass Index Exposure and Change in Monoclonal Protein Level in Veterans Diagnosed with Monoclonal Gammopathy of Undetermined Significance

Lawrence W Liu, Ekaterina Proskuriakova, Mei Wang, Murali Janakiram, Martin William Schoen, Kristen M. Sanfilippo, Theodore Thomas, Su-Hsin Chang

Blood (2024) 144 (Supplement 1): 6885.

https://doi.org/10.1182/blood-2024-206269

Published: 2024

Journal Articles

Machine Learning-Based Clinical and Laboratory Values Associated with Serum Protein Electrophoresis Testing in US Veterans

Byron Sigel, Qingyuan Tan, Mei Wang, Theodore Thomas, Kristen M. Sanfilippo, Daphne Friedman, Martin William Schoen, Su-Hsin Chang

Blood (2024) 144 (Supplement 1): 7859.

https://doi.org/10.1182/blood-2024-210974

Published: 2024

Journal Articles

The Population-Scale Analysis of DLBCL Patients Receiving Standard-Dose RCHOP Identified Impactful Prognosticators in the Real World

Chieh-Lung Cheng, Su-Mei Wang, Yu-Hsuan Tuan, Jung-Fang Liang, Anita Chen, Yun-Chun Wu, Chin-Hao Chang, Tai-Chung Huang

Blood (2024) 144 (Supplement 1): 4466.

https://doi.org/10.1182/blood-2024-209632

Published: 2024

Journal Articles

Monoclonal Protein Concentration and Risk of Multiple Myeloma: Is 0.5 g/DL the New 1.5?

Mahta Salehi, Mei Wang, Kristen M. Sanfilippo, Theodore Thomas, Martin William Schoen, Su-Hsin Chang

Blood (2023) 142 (Supplement 1): 2040.

https://doi.org/10.1182/blood-2023-190852

Published: 2023

Journal Articles

Monoclonal Gammopathy of Undetermined Significance and Risk of Cardiovascular Disease in US Veterans

Lawrence Liu, Niharika Pant, Mei Wang, Nikhil Grandhi, Ekaterina Proskuriakova, Murali Janakiram, Theodore Thomas, Kristen M. Sanfilippo, Graham Colditz, Daphne R Friedman, Martin William Schoen, Su-Hsin Chang

Blood (2023) 142 (Supplement 1): 4773.

https://doi.org/10.1182/blood-2023-185155

Published: 2023

Journal Articles

Clinical and Laboratory Indications for Serum Protein Electrophoresis Testing in US Veterans: A Retrospective Cohort Study

Niharika Pant, Lawrence Liu, Mei Wang, Nikhil Grandhi, Theodore Thomas, Kristen M. Sanfilippo, Graham Colditz, Daphne R Friedman, Martin William Schoen, Su-Hsin Chang

Blood (2023) 142 (Supplement 1): 4778.

https://doi.org/10.1182/blood-2023-190735

Published: 2023

Journal Articles

Racial Differences in the Association of Glucagon-like Peptide 1 Agonist Use and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in US Veterans with Diabetes Mellitus

Nikhil Grandhi, Lawrence Liu, Mei Wang, Theodore Thomas, Akhil Kumar, Feng Gao, Kristen M. Sanfilippo, Graham Colditz, Su-Hsin Chang

Blood (2023) 142 (Supplement 1): 4772.

https://doi.org/10.1182/blood-2023-179135

Published: 2023

Journal Articles

The Association between Body Mass Index Trajectory and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Lawrence Liu, Nikhil Grandhi, Mei Wang, Theodore S. Thomas, Akhil Kumar, Kristin Vargo, Kristen M. Sanfilippo, Graham A Colditz, Su-Hsin Chang

Blood (2022) 140 (Supplement 1): 4283–4284.

https://doi.org/10.1182/blood-2022-167126

Published: 2022

Journal Articles

Racial Difference in Dynamic Markers for Progression of MGUS Using Machine Learning Approaches

Yaochi Yu, Mei Wang, Lawrence Liu, Theodore S. Thomas, Martin Schoen, Kristen M. Sanfilippo, Graham A Colditz, Jr-Shin Li, Su-Hsin Chang

Blood (2022) 140 (Supplement 1): 7830–7831.

https://doi.org/10.1182/blood-2022-167464

Published: 2022

Journal Articles

The Association of Agent Orange Exposure Duration with Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma Progression: A Population-Based Study

Lawrence Liu, Mei Wang, Nikhil Grandhi, Mark A. Schroeder, Theodore S. Thomas, Akhil Kumar, Kristin Vargo, Feng Gao, Kristen M. Sanfilippo, Su-Hsin Chang

Blood (2022) 140 (Supplement 1): 4356–4357.

https://doi.org/10.1182/blood-2022-167305

Published: 2022

Journal Articles

Association between SLGT2 Inhibitor Use and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Nikhil Grandhi, Lawrence Liu, Mei Wang, Theodore S. Thomas, Kristen M. Sanfilippo, Feng Gao, Graham A Colditz, Su-Hsin Chang

Blood (2022) 140 (Supplement 1): 10022–10023.

https://doi.org/10.1182/blood-2022-167846

Published: 2022

Journal Articles

Preliminary Biomarker Data from a Phase 1/2 Study of Golidocitinib Demonstrates Targeting JAK/STAT Pathway to Treat Peripheral T-Cell Lymphoma

Yuqin Song, Won-Seog Kim, Dok-Hyun Yoon, Haiyan Yang, Junning Cao, Dongmei Ji, Youngil Koh, Hongmei Jing, Hyeon-Seok Eom, Jae-Yong Kwak, Won-Sik Lee, Jong-Seok Lee, Ho-Jin Shin, Jie Jin, Mei Wang, Jingrun Li, Jun Zhu

Blood (2022) 140 (Supplement 1): 6545–6546.

https://doi.org/10.1182/blood-2022-162947

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Impact of slim-CRAB criteria on diagnostic practices among patients with MGUS in the veteran health administration

Association between monoclonal gammopathy of undetermined significance and cardiovascular disease risk among individuals with type 2 diabetes: A Taiwan nationwide Study

Impact of slim-CRAB criteria on treatment initiation in newly diagnosed multiple myeloma in the veteran health administration

Identification of dynamic markers for multiple myeloma in patients with MGUS and T2DM

The association between sglt-2 inhibitor use and progression from monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans

Descriptive analysis of IgM monoclonal gammopathy of undetermined significance progression events in US veterans

Type 2 Diabetes Mellitus Increases the Risk for Developing Monoclonal Gammopathy of Undetermined Significance in Asian Populations

The Association between Rheumatological Diseases and Monoclonal Gammopathy of Undetermined Significance

The Association between Cumulative Excess Body Mass Index Exposure and Change in Monoclonal Protein Level in Veterans Diagnosed with Monoclonal Gammopathy of Undetermined Significance

Machine Learning-Based Clinical and Laboratory Values Associated with Serum Protein Electrophoresis Testing in US Veterans

The Population-Scale Analysis of DLBCL Patients Receiving Standard-Dose RCHOP Identified Impactful Prognosticators in the Real World

Monoclonal Protein Concentration and Risk of Multiple Myeloma: Is 0.5 g/DL the New 1.5?

Monoclonal Gammopathy of Undetermined Significance and Risk of Cardiovascular Disease in US Veterans

Clinical and Laboratory Indications for Serum Protein Electrophoresis Testing in US Veterans: A Retrospective Cohort Study

Racial Differences in the Association of Glucagon-like Peptide 1 Agonist Use and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in US Veterans with Diabetes Mellitus

The Association between Body Mass Index Trajectory and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Racial Difference in Dynamic Markers for Progression of MGUS Using Machine Learning Approaches

The Association of Agent Orange Exposure Duration with Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma Progression: A Population-Based Study

Association between SLGT2 Inhibitor Use and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Preliminary Biomarker Data from a Phase 1/2 Study of Golidocitinib Demonstrates Targeting JAK/STAT Pathway to Treat Peripheral T-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only